Rebastinib, CAS [[1020172-07-9]]

Produktübersicht

• Artikelname: Rebastinib, CAS [[1020172-07-9]]
• Artikelnummer: MCE-HY-13024
• Hersteller Artikelnummer: HY-13024
• Alternativnummer: MCE-HY-13024-100MG,MCE-HY-13024-25MG,MCE-HY-13024-50MG,MCE-HY-13024-10MMX1ML,MCE-HY-13024-10MG,MCE-HY-13024-200MG,MCE-HY-13024-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: DCC-2036

Produktbeschreibung

Rebastinib (DCC-2036) is an orally active, non-ATP-competitive Bcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. Rebastinib also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit.

Produkteigenschaften

• Molekulargewicht: 553.59
• Reinheit: 99.91
• CAS Nummer: [1020172-07-9]
• Formel: C30H28FN7O3
• Target-Kategorie: Apoptosis,Bcr-Abl,FLT3,Src

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound